Medium and high doses improved movement quality in up to 100% of the animals in a dose-dependent manner TORONTO and HAIFA, Israel, July 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is pleased to...Read more
Investigator initiated exploratory clinical study being conducted in Israel pursuant to agreement with collaboration partner, PeriNess Company evaluating systemic recombinant human DNase I (DNase I) in combination with chemotherapy and immunotherapy platforms for the treatment of...Read more
Comparison with multiple landmark first-line metastatic pancreatic ductal adenocarcinoma studies substantiates strong two-year survival benefit of 21.9% vs. 9.2% historical benchmark Consistent survival benefit compared to standard-of-care chemotherapy in randomized studies in...Read more
SGT-501 is a novel gene therapy for rare, life-threatening, genetic arrhythmogenic disease with no approved therapies SGT-501 has received Orphan Drug Designation and Rare Pediatric Disease Designation from the FDA Solid expects to initiate Phase 1b clinical trial of SGT-501 in the...Read more
Accepted IND application allows for development program to move directly to a Phase 2 pivotal registration clinical trial Phase 2 clinical trial initiation anticipated in first half of 2026 Pediatric cardiomyopathies affect at least 100,000 children worldwide Effective treatment options are...Read more
Submission is based on long-term Phase 3 data demonstrating 63 percent reduction in risk of relapse in adults with schizophrenia compared to placebo CAPLYTA® is FDA approved to treat schizophrenia and is the first and only approved treatment for bipolar I and II depression as an adjunctive and...Read more
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORE| Company | Change | Last Trade |
|---|---|---|
| Mettler-Toledo | 17.99 1.51 | $1,206.53 |
| Nutex Health | 12.10 9.62 | $137.83 |
| Regeneron Pharmaceuticals | 9.64 1.79 | $547.75 |
| Thermo Fisher Scientific | 8.94 2.14 | $427.64 |
| Vertex Pharmaceuticals | 6.95 1.51 | $466.36 |
| Inspire Medical Systems | 6.54 5.15 | $133.45 |
| Bolt Biotherapeutics | 5.66 1,010.71 | $6.22 |
| Chemed | 5.20 1.13 | $465.90 |
| Eli Lilly | 4.79 0.62 | $777.66 |
| ENDRA Life Sciences | 4.75 137.28 | $8.21 |
| Charles River Laboratories | 4.49 2.92 | $158.39 |
| Biogen | 4.33 3.33 | $134.46 |
| Merit Medical Systems | 4.22 4.63 | $95.34 |
| Repligen | 4.13 3.32 | $128.56 |
| Amgen | 4.05 1.38 | $297.00 |
| United Therapeutics | 4.03 1.39 | $294.42 |
| ICON | 3.99 2.70 | $151.58 |
| UnitedHealth | 3.99 1.31 | $307.70 |
| Company | Volume | Last Trade |
|---|---|---|
| ProKidney | 857,376,038 | $4.11 |
| ZyVersa Therapeutics | 206,657,633 | $0.79 |
| Healthcare Triangle | 168,752,051 | $0.02 |
| Rallybio | 150,679,662 | $0.51 |
| Plus Therapeutics | 97,500,006 | $0.33 |
| Moleculin Biotech | 91,773,496 | $0.53 |
| ENDRA Life Sciences | 90,411,678 | $8.21 |
| NuCana | 53,128,036 | $0.06 |
| CARGO Therapeutics | 48,918,856 | $4.58 |
| Pfizer | 46,778,213 | $25.62 |
| Recursion | 45,023,324 | $5.36 |
| Oscar Health | 40,077,311 | $16.56 |
| Incannex Healthcare | 33,345,203 | $0.22 |
| Vor Bio | 30,627,204 | $2.45 |
| Humacyte | 28,457,273 | $2.60 |
| SeaStar Medical | 22,360,278 | $0.81 |
| Iovance Biotherapeutics | 20,296,991 | $1.77 |
| Calidi Biotherapeutics | 19,442,620 | $0.34 |
| Moderna | 18,466,944 | $32.54 |
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORE
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORE
Assertio is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital, and pain and inflammation. Assertio has grown through...
CLICK TO LEARN MORE
Viking Therapeutics is a clinical-stage biopharmaceutical company focused on the development of novel first-in-class or best-in-class therapies for the treatment of metabolic and endocrine disorders, with three compounds currently in clinical trials. Viking’s research and development activities leverage...
CLICK TO LEARN MORE
